On October 4, 2022, Vergent Bioscience, Inc. closed the transaction. The company raised $21,542,628 in a round of funding led by new investor Orlando Health Ventures. The transaction included participation from new investors Intuitive Surgical, Inc., Windham Venture Management, LLC, Rex Health Ventures, as well as additional investment from existing investors Spring Mountain Capital, LP and Colle Capital Partners LP.

The company has raised $34 million in funding till date. As part of the transaction Margo Shoup from Orlando Health Ventures joined the board of the company. The transaction included participation from total 27 investors.

The company issued 35,982,342 shares in the transaction.